Table of Contents

Select this article
- Y Loewenstein-Lichtenstein,
- D Glick,
- N Gluzman,
- M Sternfeld,
- H Zakut,
- and H Soreq
Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis.
Mol Pharmacol December 1996 50:1423-1431
- Abstract
- Full Text (PDF)
Select this article
- J S Saulnier-Blache,
- Q Yang,
- J D Sherlock,
- and S M Lanier
Analysis of the alpha2C-adrenergic receptor gene promoter and its cell-type-specific activity.
Mol Pharmacol December 1996 50:1432-1442
- Abstract
- Full Text (PDF)
Select this article
- M Hohenegger,
- M Matyash,
- K Poussu,
- A Herrmann-Frank,
- S Sarközi,
- F Lehmann-Horn,
- and M Freissmuth
Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogs.
Mol Pharmacol December 1996 50:1443-1453
- Abstract
- Full Text (PDF)
Select this article
- J Zhang,
- A J Watson,
- M R Probst,
- E Minehart,
- and O Hankinson
Basis for the loss of aryl hydrocarbon receptor gene expression in clones of a mouse hepatoma cell line.
Mol Pharmacol December 1996 50:1454-1462
- Abstract
- Full Text (PDF)
Select this article
- M Cornarotti,
- S Tinelli,
- E Willmore,
- F Zunino,
- L M Fisher,
- C A Austin,
- and G Capranico
Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180).
Mol Pharmacol December 1996 50:1463-1471
- Abstract
- Full Text (PDF)
Select this article
- A Fujimori,
- M Gupta,
- Y Hoki,
- and Y Pommier
Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair.
Mol Pharmacol December 1996 50:1472-1478
- Abstract
- Full Text (PDF)
Select this article
- D J MacEwan and
- G Milligan
Inverse agonist-induced up-regulation of the human beta2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells.
Mol Pharmacol December 1996 50:1479-1486
- Abstract
- Full Text (PDF)
Select this article
- A J Stewart,
- C Pichon,
- L Meunier,
- P Midoux,
- M Monsigny,
- and A C Roche
Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine.
Mol Pharmacol December 1996 50:1487-1494
- Abstract
- Full Text (PDF)
Select this article
- Y Xu,
- B A Gilbert,
- R R Rando,
- L Chen,
- and A H Tashjian, Jr
Inhibition of capacitative Ca2+ entry into cells by farnesylcysteine analogs.
Mol Pharmacol December 1996 50:1495-1501
- Abstract
- Full Text (PDF)
Select this article
- T Cihlar and
- M S Chen
Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells.
Mol Pharmacol December 1996 50:1502-1510
- Abstract
- Full Text (PDF)
Select this article
- A M Andrews,
- B Ladenheim,
- C J Epstein,
- J L Cadet,
- and D L Murphy
Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.
Mol Pharmacol December 1996 50:1511-1519
- Abstract
- Full Text (PDF)
Select this article
- J Magyar and
- G Szabo
Effects of volatile anesthetics on the G protein-regulated muscarinic potassium channel.
Mol Pharmacol December 1996 50:1520-1528
- Abstract
- Full Text (PDF)
Select this article
- S Y Yao,
- A M Ng,
- M W Ritzel,
- W P Gati,
- C E Cass,
- and J D Young
Transport of adenosine by recombinant purine- and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes.
Mol Pharmacol December 1996 50:1529-1535
- Abstract
- Full Text (PDF)
Select this article
- P A Vasey,
- N A Jones,
- S Jenkins,
- C Dive,
- and R Brown
Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance.
Mol Pharmacol December 1996 50:1536-1540
- Abstract
- Full Text (PDF)
Select this article
- V I Ilyin,
- E R Whittemore,
- J Guastella,
- E Weber,
- and R M Woodward
Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Mol Pharmacol December 1996 50:1541-1550
- Abstract
- Full Text (PDF)
Select this article
- P G Bray,
- S R Hawley,
- and S A Ward
4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake.
Mol Pharmacol December 1996 50:1551-1558
- Abstract
- Full Text (PDF)
Select this article
- P G Bray,
- S R Hawley,
- M Mungthin,
- and S A Ward
Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum.
Mol Pharmacol December 1996 50:1559-1566
- Abstract
- Full Text (PDF)
Select this article
- J E Leysen,
- W Gommeren,
- L Heylen,
- W H Luyten,
- I Van de Weyer,
- P Vanhoenacker,
- G Haegeman,
- A Schotte,
- P Van Gompel,
- R Wouters,
- and A S Lesage
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Mol Pharmacol December 1996 50:1567-1580
- Abstract
- Full Text (PDF)
Select this article
- L L Wittmer,
- Y Hu,
- M Kalkbrenner,
- A S Evers,
- C F Zorumski,
- and D F Covey
Enantioselectivity of steroid-induced gamma-aminobutyric acidA receptor modulation and anesthesia.
Mol Pharmacol December 1996 50:1581-1586
- Abstract
- Full Text (PDF)
Select this article
- R A Figler,
- S G Graber,
- M A Lindorfer,
- H Yasuda,
- J Linden,
- and J C Garrison
Reconstitution of recombinant bovine A1 adenosine receptors in Sf9 cell membranes with recombinant G proteins of defined composition.
Mol Pharmacol December 1996 50:1587-1595
- Abstract
- Full Text (PDF)
Select this article
- J Van Rampelbergh,
- P Gourlet,
- P De Neef,
- P Robberecht,
- and M Waelbroeck
Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Mol Pharmacol December 1996 50:1596-1604
- Abstract
- Full Text (PDF)
Select this article
- T M Fong,
- H Yu,
- R R Huang,
- M A Cascieri,
- and C J Swain
Relative contribution of polar interactions and conformational compatibility to the binding of neurokinin-1 receptor antagonists.
Mol Pharmacol December 1996 50:1605-1611
- Abstract
- Full Text (PDF)
Select this article
- K J Reszka and
- C F Chignell
Acid-catalyzed oxidation of the anticancer agent mitoxantrone by nitrite ions.
Mol Pharmacol December 1996 50:1612-1618
- Abstract
- Full Text (PDF)
Select this article
- E V Varga,
- X Li,
- D Stropova,
- T Zalewska,
- R S Landsman,
- R J Knapp,
- E Malatynska,
- K Kawai,
- A Mizusura,
- H Nagase,
- S N Calderon,
- K Rice,
- V J Hruby,
- W R Roeske,
- and H I Yamamura
The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists.
Mol Pharmacol December 1996 50:1619-1624
- Abstract
- Full Text (PDF)
Select this article
- H Rauer and
- S Grissmer
Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3.
Mol Pharmacol December 1996 50:1625-1634
- Abstract
- Full Text (PDF)
Select this article
- H Barbhaiya,
- R McClain,
- A Ijzerman,
- and S A Rivkees
Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding.
Mol Pharmacol December 1996 50:1635-1642
- Abstract
- Full Text (PDF)
Select this article
- A O Grant,
- J E John,
- V V Nesterenko,
- C F Starmer,
- and J R Moorman
The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels.
Mol Pharmacol December 1996 50:1643-1650
- Abstract
- Full Text (PDF)
Select this article
- T T Chiu,
- L Y Yung,
- and Y H Wong
Inverse agonistic effect of ICI-174,864 on the cloned delta-opioid receptor: role of G protein and adenylyl cyclase activation.
Mol Pharmacol December 1996 50:1651-1657
- Abstract
- Full Text (PDF)
Select this article
- S Patel,
- S Patel,
- R Marwood,
- F Emms,
- D Marston,
- P D Leeson,
- N R Curtis,
- J J Kulagowski,
- and S B Freedman
Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
Mol Pharmacol December 1996 50:1658-1664
- Abstract
- Full Text (PDF)
Select this article
- C J Price and
- L A Raymond
Evans blue antagonizes both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate receptors and modulates receptor desensitization.
Mol Pharmacol December 1996 50:1665-1671
- Abstract
- Full Text (PDF)
Select this article
- A Nguyen,
- J C Kath,
- D C Hanson,
- M S Biggers,
- P C Canniff,
- C B Donovan,
- R J Mather,
- M J Bruns,
- H Rauer,
- J Aiyar,
- A Lepple-Wienhues,
- G A Gutman,
- S Grissmer,
- M D Cahalan,
- and K G Chandy
Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.
Mol Pharmacol December 1996 50:1672-1679
- Abstract
- Full Text (PDF)
Select this article
- J J Krupp,
- B Vissel,
- S F Heinemann,
- and G L Westbrook
Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific.
Mol Pharmacol December 1996 50:1680-1688
- Abstract
- Full Text (PDF)

Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis.

Analysis of the alpha2C-adrenergic receptor gene promoter and its cell-type-specific activity.

Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogs.

Basis for the loss of aryl hydrocarbon receptor gene expression in clones of a mouse hepatoma cell line.

Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180).

Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair.

Inverse agonist-induced up-regulation of the human beta2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells.

Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine.

Inhibition of capacitative Ca2+ entry into cells by farnesylcysteine analogs.

Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells.

Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.

Effects of volatile anesthetics on the G protein-regulated muscarinic potassium channel.

Transport of adenosine by recombinant purine- and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes.

Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance.

Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.

4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake.

Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum.

Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.

Enantioselectivity of steroid-induced gamma-aminobutyric acidA receptor modulation and anesthesia.

Reconstitution of recombinant bovine A1 adenosine receptors in Sf9 cell membranes with recombinant G proteins of defined composition.

Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.

Relative contribution of polar interactions and conformational compatibility to the binding of neurokinin-1 receptor antagonists.

Acid-catalyzed oxidation of the anticancer agent mitoxantrone by nitrite ions.

The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists.

Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3.

Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding.

The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels.

Inverse agonistic effect of ICI-174,864 on the cloned delta-opioid receptor: role of G protein and adenylyl cyclase activation.

Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.

Evans blue antagonizes both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate receptors and modulates receptor desensitization.

Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.

Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific.

This Issue

Current Issue